Skip to main content
. Author manuscript; available in PMC: 2018 Mar 30.
Published in final edited form as: Ann Intern Med. 2017 May 16;166(12):876–882. doi: 10.7326/M16-2052

Table 3.

Distribution of 10-year ASCVD risk in the low-prevalence subgroups

10-year ASCVD Risk* Men < 40 years (non-smokers, non-hypertensive)
N=1,365
Women <50 years (non-smokers, non-hypertensive)
N=3,281
<0.1% 2.2% (1.5%–3.4%) 7.7% (6.8%–8.8%)
0.1% – 0.49% 44.9% (41.9%–48.0%) 58.7% (56.3%–61.1%)
0.5% – 0.99% 27.3% (24.8%–29.9%) 23.3% (21.3%–25.4%)
1.0% – 2.4% 23.3% (20.6%–25.9%) 10.0% (8.6%–11.6%)
2.5% – 4.9% 2.2% (1.6%–3.2%) 0.2% (0.1%–0.5%)
5.0% – 7.4% 0.09% (0.02%–0.4%) 0.04% (0.0%–0.3%)

Brackets show 95% confidence intervals for that subgroup.

*

Risk calculated using 2013 ACC/AHA Sex and Race specific Pooled Cohort Equations. Low-prevalence subgroups defined as those subgroups in which we could rule out a prevalence of elevated cardiovascular risk (10-year ASCVD risk >5%) of more than 1%; and included non-smoking, non-hypertensive men under age of 40 years and non-smoking, non-hypertensive women under age of 50 years.